Unicycive Therapeutics Inc

NASDAQ:UNCY   3:58:59 PM EDT
0.79
-0.04 (-4.82%)
Earnings Announcements

Unicycive Announces Full Year 2021 Financial Results

Published: 03/31/2022 12:03 GMT
Unicycive Therapeutics Inc (UNCY) - Unicycive Therapeutics Inc - As of December 31, 2021, Cash and Cash Equivalents Totaled $16.6 Million.
Unicycive Therapeutics Inc - Plans to Initiate Phase 1 Study for Uni-494 in Second Half of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.